CHASE INVESTMENT COUNSEL CORP - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 356 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.4%.

Quarter-by-quarter ownership
CHASE INVESTMENT COUNSEL CORP ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2014$2,067,000
+1.2%
13,232
-20.1%
0.74%
+7.2%
Q2 2014$2,042,000
+31.5%
16,560
+10.5%
0.69%
+31.6%
Q1 2014$1,553,000
+14.4%
14,990
-0.7%
0.53%
+30.8%
Q4 2013$1,357,00015,0900.40%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 300,000$46,872,00024.29%
HealthCor Management, L.P. 935,100$146,100,0007.50%
1492 Capital Management LLC 70,167$10,963,0006.07%
Visium Asset Management, LP 2,301,629$359,607,0005.31%
HWG Holdings LP 39,621$6,190,0004.97%
Riggs Asset Managment Co. Inc. 45,649$7,132,0004.14%
Cardinal Capital Management 49,139$7,677,0003.65%
AMI ASSET MANAGEMENT CORP 213,398$33,341,0003.27%
BENNETT LAWRENCE MANAGEMENT L L C/NY 88,435$13,817,0003.14%
Adamant Biomedical Investments AG 78,210$12,220,0003.05%
View complete list of SALIX PHARMACEUTICALS INC shareholders